Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hand-foot-yan Ning (also known as Shou-Zu-Yan-Ning) is a Traditional Chinese Medicine (TCM) hospital preparation developed by Tongji Hospital of Huazhong University of Science and Technology. It is specifically formulated for the prevention and treatment of hand-foot syndrome (HFS), a common dermatological side effect of chemotherapy agents such as capecitabine and 5-fluorouracil. The preparation consists of a combination of herbal extracts, including *Sophora flavescens*, *Phellodendron amurense*, *Carthamus tinctorius*, *Spatholobus suberectus*, and *Glycyrrhiza uralensis*, which collectively exert anti-inflammatory, analgesic, and microcirculation-improving properties. It is typically administered as a topical soak or wash. Clinical studies, including Phase 3 trials, have suggested that it can significantly reduce the incidence and severity of HFS, improving the quality of life for cancer patients and allowing for the maintenance of chemotherapy dosing schedules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hand-foot-yan Ning.